… Fuzheng Kang'ai Formula (扶正抗癌方) in patients with advanced non-small cell lung cancer with epidermal growth factor receptor mutation: a randomized controlled …
X Yang, X Chai, W Wu, S Long, H Deng, Z Pan… - Chinese journal of …, 2018 - Springer
… noninferiority in overall survival between gefitinib and docetaxel … Second, the sample size
of our study was not large enough. … on clinical outcomes in previously untreated non-small cell …
of our study was not large enough. … on clinical outcomes in previously untreated non-small cell …
贝伐珠单抗联合埃克替尼克服一例非小细胞肺癌患者奥希替尼耐药
张玲， 孙雷， 穆晓燕， 季有信 - Chinese Medical Sciences Journal, 2019 - cmsj.cams.cn
… with epidermal growth factor receptor (EGFR) 19 del mutation … Among them, EGFR C797S/G
mutation happened in 20%-60… were in vitro or in vivo, the clinical outcomes were unclear. …
mutation happened in 20%-60… were in vitro or in vivo, the clinical outcomes were unclear. …
第三代EGFR-TKIs 治疗晚期非小细胞肺癌的耐药机制及应对策略研究进展
何婧怡， 吴芳， 胡春宏 - 肿瘤防治研究, 2019 - zlfzyj.com
… of epidermal growth factor receptor tyrosine kinase inhibitor (… firstand second-generation
EGFR-TKIs. The third-generation … among non-small-cell lung cancers harboring EGFR exon 20 …
EGFR-TKIs. The third-generation … among non-small-cell lung cancers harboring EGFR exon 20 …
EGFR T790M 突变在非小细胞肺癌中的研究进展
侯冉， 胡泊， 史健 - 肿瘤防治研究, 2020 - zlfzyj.com
… the relation between T790M mutation and EGFR-TKIs, … new secondary drug resistance
of the third generation of EGFR-… Activating mutations in the epidermal growth factor receptor …
of the third generation of EGFR-… Activating mutations in the epidermal growth factor receptor …
[PDF][PDF] 奥希替尼治疗获得性表皮生长因子受体-酪氨酸激酶抑制剂耐药T790M 突变肺腺癌晚期1 例
叶贯超， 齐宇， 宋亚男， 韩露， 刘亚飞， 董博… - 临床与病理 …, 2020 - cdn.amegroups.cn
… of epithelial growth factor receptor (EGFR) gene 19 exon deletion … The results of the second
CT-guided percutaneous lung … of a T790M mutation advanced lung adenocarcinoma patient …
CT-guided percutaneous lung … of a T790M mutation advanced lung adenocarcinoma patient …
EGFR 基因突变与肿瘤靶向治疗
薛丽a - 中国现代应用药学, 2012 - zgxdyyyx.ijournals.cn
… (epidermal growth factor receptor,EGFR)属于受体酪氨酸激酶超家族,在多种恶性肿瘤中表达.配
体与EGFR… cases with acquired resistance to TKIs have a secondary mutation (T790M) that …
体与EGFR… cases with acquired resistance to TKIs have a secondary mutation (T790M) that …
表皮生长因子受体少见突变型非小细胞肺癌临床病理特征及治疗分析
张峤， 刘翔， 李建军， 曹燕珍， 张健， 单莉 - 中国肿瘤临床, 2017 - cjco.cn
… with seldom mutation types of epidermal growth factor receptor and … Then we analyzed the
relationship between the … effects of EGFR-TKI therapy was slightly better than the second-line …
relationship between the … effects of EGFR-TKI therapy was slightly better than the second-line …
[PDF][PDF] 1 例EGFR T790M 突变阳性晚期肺腺癌的治疗策略及文献复习
全玲丽， 黄彭， 刘双柏， 梁彦超 - 临床与病理杂志, 2020 - cdn.amegroups.cn
… 生长因子受体扩增阻滞突变系统(epidermal growth factor receptor-amplification refractory …
the EGFR T790M mutation in patients who are resistant to the first- or secondgeneration TKIs, …
the EGFR T790M mutation in patients who are resistant to the first- or secondgeneration TKIs, …
奥希替尼治疗62 例晚期肺腺癌患者的临床疗效观察
高志强， 王韡旻， 蔡雨晴， 秦若琰， 顾爱琴… - 中国癌症 …, 2019 - china-oncology.com
… or secondary drug resistance to epidermal growth factor … Results: Among the 62 patients
with advanced lung … 表皮生长因子受体(epidermal growth factor receptor,EGFR)的基因突变率最 …
with advanced lung … 表皮生长因子受体(epidermal growth factor receptor,EGFR)的基因突变率最 …
[PDF][PDF] EGFR 突变肺腺癌靶向联合全脑放疗后假性进展1 例并文献复习
张萍， 甄婵军， 白文文， 陈明月， 于汶卉… - 临床与病理杂志, 2020 - cdn.amegroups.cn
… 抑制剂(epidermal growth factor receptor-tyrosine kinase inhibitor,… , the results of the genetic
test again suggested that the T790M … Therefore, the second-line treatment was replaced to …
test again suggested that the T790M … Therefore, the second-line treatment was replaced to …